United States · FDA National Drug Code directory
Plerixafor
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 25021-416_69c3fb68-4dfb-43db-bc59-421e4b3dfa0c
- Product NDC
- 25021-416
- Form
- INJECTION, SOLUTION
- Composition / generic term
- Plerixafor
- Labeler
- Sagent Pharmaceuticals
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20240801
- Source listing expiry
- 20261231
Source-listed ingredients
- PLERIXAFOR — 20 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL in 1 CARTON (25021-416-01) / 1.2 mL in 1 VIAL · 25021-416-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →